Use of apheresis in the age of new therapies for familial hypercholesterolaemia-Reference-Cited by-同舟云学术

Use of apheresis in the age of new therapies for familial hypercholesterolaemia

Published:2021-09-22 Issue:6 Volume:32 Page:363-369
ISSN:0957-9672
Container-title:Current Opinion in Lipidology
language:en
Short-container-title:

Author:

Thompson Gilbert R.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cell Biology,Cardiology and Cardiovascular Medicine,Nutrition and Dietetics,Genetics,Molecular Biology,Endocrinology, Diabetes and Metabolism

Reference53 articles.

1. Formes homozygotes cutane-tendineuses de xanthomatose hypercholésterolémique dans une observation familiale exemplaire. Essai de plasmaphèrése à titre de traitment héroique;De Gennes;Bull Mem Soc Hop Paris,1967

2. Plasma exchange in the management of homozygous familial hypercholesterolaemia;Thompson;Lancet,1975

3. Application of specific extracorporeal removal of low density lipoprotein in familial hypercholesterolaemia;Stoffel;Lancet,1981

4. Current role of lipoprotein apheresis;Thompson;Curr Atheroscler Rep,2019

5. Lipoprotein apheresis efficacy, challenges and outcomes: a descriptive analysis from the UK Lipoprotein Apheresis Registry, 1989–2017;Pottle;Atherosclerosis,2019

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. International Atherosclerosis Society Roadmap for Familial Hypercholesterolaemia;Global Heart;2024

2. Long-term outcomes of liver transplantation for homozygous familial hypercholesterolaemia in Australia and New Zealand;Atherosclerosis;2023-12

3. Recent advances in the management and implementation of care for familial hypercholesterolaemia;Pharmacological Research;2023-08

4. Advancements in the Treatment of Homozygous Familial Hypercholesterolemia;Journal of Atherosclerosis and Thrombosis;2022-08-01